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Abstract
Background: Previously, we demonstrated that poorly differentiated cells of various origins, including tumor-initiating
stem cells present in the ascites form of mouse cancer cell line Krebs-2, are capable of naturally internalizing both linear
double-stranded DNA and circular plasmid DNA.
Methods: The method of co-incubating Krebs-2 cells with extracellular plasmid DNA (pUC19) or TAMRA-5’-dUTP-labeled
polymerase chain reaction (PCR) product was used. It was found that internalized plasmid DNA isolated from Krebs-2 can
be transformed into competent Escherichia coli cells. Thus, the internalization processes taking place in the Krebs-2 cell
subpopulation have been analyzed and compared, as assayed by E. coli colony formation assay (plasmid DNA) and
cytofluorescence (TAMRA-DNA).
Results: We showed that extracellular DNA both in the form of plasmid DNA and a PCR product is internalized by the
same subpopulation of Krebs-2 cells. We found that the saturation threshold for Krebs-2 ascites cells is 0.5 μg DNA/106
cells. Supercoiled plasmid DNA, human high-molecular weight DNA, and 500 bp PCR fragments are internalized into the
Krebs-2 tumor-initiating stem cells via distinct, non-competing internalization pathways. Under our experimental
conditions, each cell may harbor 340–2600 copies of intact plasmid material, or up to 3.097 ± 0.044×106 plasmid copies
(intact or not), as detected by quantitative PCR.
Conclusion: The internalization dynamics of extracellular DNA, copy number of the plasmids taken up by the cells, and
competition between different types of double-stranded DNA upon internalization into tumor-initiating stem cells of
mouse ascites Krebs-2 have been comprehensively analyzed. Investigation of the extracellular DNA internalization into
tumor-initiating stem cells is an important part of understanding their properties and possible destruction mechanisms.
For example, a TAMRA-labeled DNA probe may serve as an instrument to develop a target for the therapy of cancer,
aiming at elimination of tumor stem cells, as well as developing a straightforward test system for the quantification of
poorly differentiated cells, including tumor-initiating stem cells, in the bulk tumor sample (biopsy or surgery specimen).
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Background
Studies of DNA internalization by eukaryotic cells has
become increasingly popular. It is well known that extra-
cellular DNA (eDNA) can be directed into cells using
transfection agents, such as lipofectamine and polyplexes
[20, 37, 39]. However, eDNA has also been reported to
become directly delivered to cells without the use of
additional transfection tools [5, 11, 12, 14, 19, 34, 40].
Furthermore, upon internalization, eDNA sequences
may become expressed [6, 14, 19].
Neither the exact mechanisms of how eDNA becomes in-
ternalized, nor the factors aiding in this process, have been
comprehensively characterized. One mechanism established
to mediate internalization of eDNA is endocytosis [2, 22]. In
this scenario, eDNA molecules interact either with cell
membrane components (adsorption endocytosis) or with
appropriate cell receptors (receptor-mediated endocytosis)
[28]. Experimental data are available showing that DNA
molecules are transported into lymphocytes, monocytes,
neutrophils, and skeletal myocytes via interaction with cell
surface proteins [4, 15, 18, 35, 40]. However, most of these
DNA-binding cell surface proteins have received surprisingly
little attention and so their exact role in the internalization
process still remains obscure. It has also been demonstrated
that short nucleic acid fragments can penetrate the cell
interior using special channels [7, 17, 24, 30, 36].
Our earlier studies ([12, 33] and Krebs-2 transcriptome
analysis (data not shown)) indicate that Krebs-2 cells cap-
able of internalizing eDNA (TAMRA+ cells) display prop-
erties of tumor-initiating cancer stem cells. Notably, this
property is also shared by clonogenic glioma [12], multiple
myeloma, and lymphoma cells (data not shown).
Both linear double-stranded DNA (dsDNA) and super-
coiled plasmid DNA were shown to be taken up by
Krebs-2 cells [12]. Whether these DNA species may
compete with each other during internalization, and
which mechanisms and factors are involved, is the focus
of our research.
In the present paper, we describe internalization of
pUC19 plasmid DNA by ascites cells of mouse cell line
Krebs-2. We explore the efficiency of plasmid DNA
internalization depending on its concentration in the
medium and the incubation time. Next, we estimate
whether various DNA species may competitively influ-
ence the internalization of each other (human dsDNA
(0.3–6 kb) versus polymerase chain reaction (PCR) frag-
ment (0.5 kb) versus supercoiled plasmid DNA) upon
co-incubation with Krebs-2 ascites cells.
Methods
Laboratory animals and tumor model
We used 2- to 3-month-old CBA/Lac mice bred in the
animal facility at the Institute of Cytology and Genetics,
Siberian Branch of the Russian Academy of Sciences.
Animals were grown in groups of 5–10 mice per cage
with free access to food and water. The Ascites form of
the mouse carcinoma Krebs-2 (derived from the solid
form) was used as a model [21]. This cancer cell line
was obtained from the cell depository of the Institute of
Cytology and Genetics (Novosibirsk, Russia) and is
maintained in mice as a transplanted tumor. To obtain
ascites, Krebs-2 cells were diluted 1:10 in 200 μl normal
saline and inoculated intraperitoneally (2 × 106 cells).
TAMRA labeling of human Alu repeat DNA and
incubation of extracellular DNA with ascites Krebs-2 cells
DNA was labeled with TAMRA-5’-dUTP (N-90100, Bio-
san, Novosibirsk) using PCR. The PCR template was
human Alu repeat material cloned in pBlueScript SK(+)
(Alu-pBS), this repeat encompassing the tandemly
repeated AluJ and AluY sequences (NCBI: AC002400.1,
53494–53767). Standard M13 primers were used for amp-
lification. PCR purification was done by standard phenol-
chloroform extraction followed by ethanol precipitation
using ammonium acetate as a salt. The quantity of eDNA
being added to the cells (Alu-TAMRA DNA, pUC19
(#440060, Medigen, Novosibirsk), pEGFP-N1 (#6085-1,
Clontech), sonicated pEGFP-N1) was 1 μg plasmid DNA/
106 cells and 0.2 μg Alu-TAMRA DNA/106 cells. The cells
that incorporated the fluorescently labeled DNA probe
were analyzed by either FACS (BD FACSAria, Becton
Dickinson) or by fluorescence microscopy (laser scanning
microscope LSM 510 META (Zeiss), ZEN software or
AxioImager ZI microscope (Zeiss), ISIS software).
Saturation of Krebs-2 cells with pUC19 plasmid DNA and
estimates of the copy number of internalized pUC19
One million Krebs-2 cells were incubated for 1 h with
pUC19 plasmid DNA (0.01; 0.1; 1; 5; 10; 20 μg). Next, to
eliminate non-internalized DNA, the cells were treated
with DNaseI (#18525, Serva) (10 μg/ml, 37 °С, 1 h),
washed once with RPMI-1640 medium (#1.3.4, Biolot, St.
Petersburg, Russia), and resuspended in 50 mM EDTA.
SDS was added to a final concentration of 1 % and pro-
teinase K (BIO-405010, Bioron GmbH, Germany) treat-
ment (100 μg/ml) was performed at 58 °С for 1 h. Cell
lysate was subjected to phenol-chloroform extraction, and
the DNA was re-precipitated with 0.6 volumes of isopro-
panol, washed with 70 % ethanol and dissolved in water
(15–40 μl). The DNA thus obtained was transformed into
chemically competent XL1Blue MRF' E. coli cells. The
cells were spread on agar-Amp plates. Colonies were
counted, and this information was used to estimate plas-
mid copy number per cell. To verify that the transformed
cells indeed carried the intended pUC19 plasmid, several
individual colonies were grown in LB-Amp overnight.
Plasmid DNA was purified and its identity was confirmed
by gel electrophoresis.
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Plasmid copy number estimate
The following input data were available to us: 1) E. coli
transformation efficiency (transformation of 10 pg pUC19
plasmid DNA produced 200 colonies upon transformation);
2) 10 pg of pUC19 plasmid (2.9 kb) translates into 4.6 × 106
plasmid copies; 3) the number of colonies formed upon
transformation of DNA isolated from Krebs-2 cells incu-
bated with pUC19; 4) the percentage of DNA-internalizing
cells among all Krebs-2 cells is 3 % on average. Thereby, we
can estimate how many cells in fact internalize DNA—3 %
of 1 million cells equals 3 × 104 cells,
Based on the proportion between 200 colonies and
4.6 × 106 plasmid molecules, and the known number of
colonies obtained in the experimental point (N), one can
estimate how many plasmid molecules were present (X).
Therefore, each cell internalized on average X/3 × 104
plasmid molecules.
Analysis of co-internalization of pUC19 and Alu-TAMRA
DNA by Krebs-2 ascites cells
The cells were incubated with a mixture of 1 μg pUC19
and 0.2 μg Alu-TAMRA DNA (per one million Krebs-2
cells). Following a single wash, TAMRA+ cells were sorted
using BD FACSAria flow cytometer (Becton Dickinson).
Flow-sorted cells were subjected to all the treatments
(starting from the DNaseI step) described in the above
section of the Methods.
Analysis of competition between different types of eDNA
Alu-TAMRA DNA, pUC19 (see “TAMRA labeling of
human Alu repeat DNA and incubation of extracellular
DNA with ascites Krebs-2 cells” section above), and
human dsDNA (300–6000 bp) were used. Human DNA
was isolated from placentas of healthy women using a
phenol-free method, and sonicated as described in [1].
Krebs-2 cells were incubated for 1 h with the first type
of eDNA, according to the above protocol. Next the cells
were washed once with RPMI-1640 and resuspended in
this medium. The second type of DNA was either added
immediately, or the cells were left at 37 °C in the
medium supplemented with 10 % fetal bovine serum
(FBS; SH30071.03, HyClone, USA) until the second type
of DNA was added. After the incubation with the second
type of eDNA, Krebs-2 cells were washed with medium
and subjected to all the procedures described in the
“TAMRA labeling of human Alu repeat DNA and incu-
bation of extracellular DNA with ascites Krebs-2 cells”
section above.
Cell cycle analysis of TAMRA+ and unsorted Krebs-2 cells
Sorted TAMRA+ or unsorted Krebs-2 cells were centri-
fuged at 400 g, 4 °С for 5 min, and fixed in 60 % methanol
for 1 h at 4 °С. The cell suspension was pelleted, washed
with phosphate-buffered saline (PBS), and treated with
200 μg/ml RNase (LLC Samson-Med, St. Petersburg,
Russia) for 30 min at 37 °С. Next, propidium iodide
(P4170, Sigma-Aldrich) was added to the cell suspension
for 10 min at room temperature. Cell cycle profiling was
performed using BD FACSAria flow cytometer (Becton
Dickinson).
Quantitative PCR quantification of eDNA copy number in
Krebs-2 cells
Isolation of DNA
Following incubation of Krebs-2 cells with eDNA and
DNaseI treatment, the cell membrane was lysed with
0.5 % Triton-X100 (#37238, Serva) (15 min on ice). Nuclei
were pelleted by centrifugation at 200 g for 5 min at 4 °C.
Supernatants were collected and DNA was precipitated by
adding 0.6 volumes of isopropanol. The pellets were re-
dissolved in a small volume of water. Nuclear pellets were
resuspended in 50 mM EDTA, SDS was added to 1 %, and
samples were treated with proteinase K. DNA was purified
by phenol-chloroform extraction and re-precipitated as
described above.
Quantitative PCR and calibration curve
DNA molecules were quantified by real-time PCR using
SYBR Green PCR Master Mix (#4309155, Applied Biosys-
tems, UK). To generate the quantitative PCR (qPCR) cali-
bration curve, standard M13 primers or primers from the
Amp gene (forward: 5’-ATGAGTATTCAACATTTCCG-
3’; reverse: 5’-GATCTTACCGCTGTTGAGAT-3’) were
used, and 0, 0.5, 5, 50, 500, 5000 and 50,000 pg of each
pUC19 and Alu-repeat DNA were added to the reactions.
Each concentration was run in triplicate. The linear fit of
Ct versus eDNA content was plotted using StepOne Soft-
ware v2.3. pUC19 and Alu DNA present in the nuclear or
cytoplasmic fractions of Krebs-2 cells was quantified using
StepOne Software v2.3. Template DNA (100 ng) was
added to each qPCR reaction. DNA isolated from intact
Krebs-2 cells was used as a negative control (and no prod-
uct whatsoever was observed). All real-time PCR experi-
ments were performed in triplicate and repeated twice on
a Step One Real-Time PCR System (Applied Biosystems).
Conversion of qPCR data into eDNA copy numbers
Calibration curve-based qPCR data were converted into
absolute plasmid or Alu-repeat molecule numbers as fol-
lows: 100 ng of Krebs-2 DNA added to each qPCR
equals ~8333 cells (12 pg/cell). Given than TAMRA+
cells were shown to be the same cells as those internaliz-
ing plasmid DNA, we could estimate the exact percent-
age of cells that internalized both types of eDNA. From
fluorescence microscopy analysis, we know that 2 % of
cells were eDNA-internalizing (i.e., ~167 cells). Hence,
by dividing the eDNA copy number measured by 167,
one obtains the number of eDNA molecules per cell.
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Statistical analysis
Statistical analysis was performed using Statistica 10 soft-
ware. In the figures, bars show standard deviation (n = 3–4
at different experimental points). The level of significance
was estimated using Students t tests.
Results
Internalization of Alu-TAMRA dsDNA and supercoiled
plasmid pUC19 DNA by Krebs-2 cells
Previously, passaging the ascites in a grafted form was
demonstrated not to affect the ability of a subpopula-
tion of ascites cells (tumor-initiating stem cells (TISCs))
to internalize extracellular dsDNA in the absence of
additional transfection factors [12] (Fig. 1). The per-
centage of Krebs-2 cells that internalized Alu-TAMRA
DNA has been analyzed by confocal microscopy and
cytometry and was within the previously reported
experimental range (1–7 %), namely 3 %. Performing
the incubation of Krebs-2 cells with Alu-TAMRA DNA
at 4 °С, 25 °С, or 37 °С did not influence the efficiency
of internalization.
First and foremost, we wanted to understand whether
Krebs-2 cells internalizing linear Alu-TAMRA DNA are
the same cells that internalize supercoiled plasmid
DNA. To do this, ascites Krebs-2 cells were co-
incubated with TAMRA-labeled Alu DNA and super-
coiled pUC19 plasmid DNA. The cells were flow-sorted
into TAMRA-positive and -negative subpopulations.
Their DNA was isolated and transformed into compe-
tent E. coli cells. Upon transformation, only TAMRA+
cells produced E. coli colonies. Plasmid DNA isolated
from these colonies was identical to the original pUC19
plasmid, which was used for co-incubation experiments
(Fig. 2).
Copy number analysis of dsDNA molecules internalized
by Krebs-2 TISCs
Selective targeting of TISCs by delivery of cell-killing
genes carried on the plasmids is an attractive approach
with a clear therapeutic application. For this approach to
work, it is important to know whether non-degraded
DNA molecules are delivered to the cells and how many
native plasmid DNA molecules can be found in the cell
at a time. To address these questions, two series of
experiments were carried out. In the first series, we esti-
mated the number of plasmid DNA molecules internal-
ized by Krebs-2 cells by transformation of DNA from
such cells into competent E. coli. Also, using an E. coli
transformation assay, we determined the saturation
threshold of Krebs-2 cells, which is 1 μg/106 cells
(Fig. 3a). In the second series, the internalized plasmid
DNA was quantified directly using qPCR. Importantly,
unlike transformation, qPCR quantifies the entire pool
of DNA molecules, regardless of whether they are
nicked, partially degraded, or integrated into the genome
or not. The results expectedly differ by three orders of
magnitude: transformation experiments give an estimate
from 340 (Fig. 3a) to 2600 (data not shown) plasmid
copies/cell, with qPCR producing an estimate of 1.070 ±
0.054×106 copies/cell and 3.097 ± 0.044×106 copies/cell
(Amp and M13 primer sets, respectively) (see Methods)
(Fig. 3b-1). We also analyzed the copy number of Alu
fragments internalized by the cells, which was 0.425 ±
0.011×106 (Fig. 3b-2). Additionally, we monitored the
dynamics of Alu-TAMRA internalization by Krebs-2
TISCs. The cells become saturated with eDNA frag-
ments by the end of the first hour of incubation.
According to the confocal imaging analysis (data not
shown), internalized labeled DNA material appears to
double every 10 min.
a b
Fig. 1 Cytofluorescence (a) and flow cytometry (b) analyses of Alu-TAMRA DNA internalization by ascites Krebs-2 cells. DNA is stained with DAPI
(blue); TAMRA (red) corresponds to Alu-TAMRA DNA
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Competitive interactions between human dsDNA, yeast
RNA, bovine serum albumin, and heparin during
internalization of pUC19 by Krebs-2 cells
Next, we proceeded to characterize possible competition
between supercoiled plasmid DNA (pUC19) and linear
DNA (fragmented human genomic DNA), total yeast
RNA, bovine serum albumin (BSA), and heparin. Nei-
ther linear dsDNA (300–6000 bp), nor RNA, nor BSA
compete with plasmid DNA for internalization factors
(Fig. 4a, b and c). Amazingly, the addition of 10 U hep-
arin (7.7 μg) abolished the internalization by Krebs-2
cells (Fig. 4d). In parallel, heparin was also demonstrated
to abolish the uptake of Alu-TAMRA dsDNA by human
mesenchymal stem cells (Fig. 4e).
Competition between various eDNA types during
internalization by Krebs-2 cells
Our earlier studies showed that internalization of extra-
cellular DNA by human MCF-7 cells proceeds in two
waves, and peaks at 1 and 3 h after the beginning of
incubation [34]. In the present work, a series of experi-
ments was performed to characterize the dynamics of
eDNA internalization when Krebs-2 cells have been pre-
incubated with various types of dsDNA. Specifically, one
million Krebs-2 cells were incubated for 1 h with
different dsDNA preparations. Next, additional DNA
samples were added to the cells (once every hour, 3–4 h in
total). To eliminate non-internalized DNA (unbound or
membrane-associated DNA), the cells were finally treated
with DNaseI. All experiments involved either pUC19 plas-
mid DNA or TAMRA-labeled human Alu repeat. These
served as references for comparisons (E. coli transformation
assay for pUC19, and flow cytometry for Alu-TAMRA).
Several types of competition experiments were performed;
each was run several times to achieve statistical significance.
The following combinations were tested: pUC19 + pUC19
(Fig. 5), Alu-TAMRA+Alu-TAMRA (Fig. 6a), pUC19 +
Alu-TAMRA (Fig. 6b), total human DNA+Alu-TAMRA
(Fig. 7a), and sonicated pEGFP-N1 +Alu-TAMRA (Fig. 7b).
The reasons for choosing these specific DNA combinations
are explained below.
1. pUC19 + pUC19
First, we wanted to confirm or challenge the
existence of a second wave of internalization 3–4 h
after the beginning of incubation, as was
demonstrated for MCF-7 cells (see Methods).
Indeed, we observed that adding more plasmid DNA
3–4 h following the incubation results in significantly
more plasmids capable of forming colonies upon
a c d
b
Fig. 2 Analysis of plasmids isolated from the colonies obtained by transformation of competent E. coli cells with DNA from Krebs-2 ascites pre-incubated
with different types of eDNA (pUC19 only or pUC19 + Alu-TAMRA dsDNA). a Krebs-2 ascites cells were incubated with a mixture of plasmid pUC19 DNA
and linear Alu-TAMRA dsDNA. TAMRA+ and TAMRA– subpopulations were gated as shown. b Image of colony growth on an LB-amp plate
seeded with E. coli cells transformed with DNA from TAMRA+ or TAMRA– Krebs-2 subpopulations. No colonies are formed in the latter group.
c Agarose gel electrophoresis analysis of the plasmids recovered. 1–4, Plasmids obtained from TAMRA+ material; 5, 6, plasmids obtained from
the control transformation (Krebs-2 cells incubated with pUC19 DNA only); pUC19, Alu-pBS, original plasmids; 1 kb, DNA molecular weight
1 kb ladder. d Restriction analysis of plasmid DNA with a 4-cutter HaeIII. Plasmids derived from TAMRA+ cells (2, 3) correspond to pUC19,
much as the plasmid (6) isolated from control Krebs-2 cells incubated with just pUC19
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transformation into competent E. coli (Fig. 5a and b).
This is formally compatible with two basic scenarios:
either more internalization-competent cells become
available with time, or more plasmid copies accumulate
in the same cells. To understand which scenario is
correct, fluorescently labeled DNA was included in the
analysis (Alu-TAMRA). Using flow cytometry, we
show that there is a 20 % gain in the TAMRA+
cell subpopulation (from 1.4 % to 1.7 %) when
Alu-TAMRA DNA is added 3 h after beginning
the first incubation (Fig. 5c-1). This observation is
consistent with our earlier report [12] where the
percentage of TAMRA+ cells was found to increase
upon a longer incubation time (Fig. 5c-2). We
performed an additional experiment wherein the cells
were first incubated with Alu-TAMRA DNA, followed
by Alu-FITC DNA 3 h later. The cells were
analyzed under a fluorescence microscope. This
analysis showed that the second portion of eDNA
was largely absent from TAMRA+ cells, and is
restricted to TAMRA cells (Fig. 5d-1). Cells that
were double-positive for Alu-TAMRA and
Alu-FITC (Fig. 5d-2) were present, but were rather
rare. Taken together, these data suggest that 3–4 h
a
b
Fig. 3 Copy number analysis of eDNA internalized by Krebs-2 cells. a saturation of Krebs-2 cells with increasing amounts of pUC19 DNA in the
incubation medium. b qPCR quantification of pUC19 (1) and Alu DNA (2) present in Krebs-2 cells after co-incubation with eDNA. Linear calibration
plot was constructed using StepOne v2.3 software; each datapoint was run in triplicate
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following the beginning of the incubation there is a
13–50 % increase in the number of cells internalizing
exogenous DNA.
Next, we compared cell cycle distributions of
unsorted cells and eDNA-internalizing cells (Fig. 5e).
The two profiles were indistinguishable, with about
20 % of cells found in the G2-M phases. One can
speculate that the cells undergoing mitosis are
unlikely candidates for a cell-internalizing
subpopulation. However, upon exiting the M phase
such cells may become internalization-competent.
The timing of the second wave of internalization
events matches the length of the M phase, which is
known to be 3–4 h. Data on the percentage of
dividing cells and the increase in TAMRA+
subpopulation at a 4-h timepoint indicate that the
increase in the plasmid copy number is attributable to
the availability of an additional pool of internalization-
competent cells that were undergoing mitosis and
were incapable of internalizing DNA.
Next, we aimed to address the question whether
Alu-TAMRA PCR fragments and supercoiled DNA
are internalized using the same factors or not. Two
combinations of DNA were tested: Alu-TAMRA +
Alu-TAMRA (Fig. 6a) and pUC19 + Alu-TAMRA
(Fig. 6b). The first combination was necessary to
control for the effect of the second wave of
internalization. The second combination allowed
estimating the contribution of both types of DNA
into internalization, so as to understand whether
** **




Fig. 4 Internalization of supercoiled pUC19 plasmid DNA by Krebs-2 cells in the presence of various competitors. The relative internalization efficiency
of pUC19 plasmid DNA in the presence of different amounts of human dsDNA (a), yeast RNA (b), bovine serum albumin (BSA) (c), and heparin (d). The
values are shown on a log pUC19 (pUC19 + competitor) scale. e FACS analysis of Alu-TAMRA dsDNA internalization by human mesenchymal stem cells
(MSCs) in the presence or absence of heparin. The data obtained suggest that heparin is a dose-dependent inhibitor of plasmid DNA internalization
and suppresses linear DNA internalization by the cells. *p < 0.05; **p < 0.01; #p < 0.001




Fig. 5 Internalization of eDNA by Krebs-2 cells upon additional rounds of incubation. a Internalization of pUC19 plasmid was analyzed when this
plasmid was added every 30 min (groups 2–6) following 1-h pre-incubation with 1 μg pUC19 (group 1). Shown is the total number of colonies
obtained by transforming competent E. coli with DNA from 106 Krebs-2 cells incubated with pUC19 DNA; b representative image of E. coli
colonies that formed as a result of transformation of DNA isolated from Krebs-2 cells that received additional pUC19 DNA 2.5 (group 5) and 3 h
(group 6) after the pre-incubation step. Many more colonies are visible on the group 6 half of the plate; c FACS analysis of Alu-TAMRA dsDNA
internalization by Krebs-2 cells 3 h following the pre-incubation with the same DNA; d fluorescence microscopy analysis of Krebs-2 cells
pre-incubated with Alu-TAMRA DNA, followed by addition of Alu-FITC DNA. Cells internalizing fluorescent probes are marked with arrows;
e cell cycle profiling of the total (unsorted) cell population (top), and TAMRA+ Krebs-2 cells (bottom). Percentages of cells found in G1, S,
and G2/M phases are shaded in red
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internalization factors used for Alu-TAMRA and
plasmid DNA are the same.
2. Alu-TAMRA + Alu-TAMRA
When Krebs-2 cells are pre-incubated with
Alu-TAMRA DNA and then additional portions of
the same DNA are introduced, the pre-incubation
step should saturate all the G1-S cells available and
no increase in TAMRA-positive cells should be
observed during the first 3–4 h. The increase in
internalizing cells (about 20 %) should, however, be
observed after the 3–4 h timepoint, which corresponds
to the percentage of cells found in G2-M phases in the
beginning of the experiment. Data obtained for
Alu-TAMRA DNA appear similar to those obtained
for the plasmid DNA, i.e., there is no internalization
during the first 3 h and a second wave of
internalization events follows immediately after
(Fig. 6a 1–6). The plot shown in Fig. 6a indicates that
the percentage of TAMRA+ cells remains unchanged
at 1-h, 2-h, and 3-h timepoints (upper limit).
However, it does increase some 13 % later on
(from 2.6 % to 3.3 %) (Fig. 6a 2,5,6).
3. pUC19 + Alu-TAMRA
Should the factor controlling internalization of
Alu-TAMRA and plasmid DNA be the same,
pre-incubation of Krebs-2 cells with plasmid DNA
a b
Fig. 6 Competition between Alu-TAMRA dsDNA and supercoiled pUC19 plasmid DNA for internalization into Krebs-2 cells. a Alu-TAMRA DNA is
added 1 h after pre-incubation with the same DNA. b Alu-TAMRA DNA is added after pre-incubation with pUC19. 1a-5a, 1b-6b, Flow cytometry
plots and schematics of each experimental point analyzed; 6a, 7b, percentage of TAMRA+ cells analyzed at each point. Baseline equals
background level of fluorescence, i.e., either when no DNA was added (a), or when cells were incubated for 1 h with non-fluorescent
plasmid DNA (b); upper limit represents percentage of TAMRA+ cells following incubation with Alu-TAMRA DNA
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should prevent TAMRA+ cells from appearing
following the incubation steps, and thus
internalization above the “upper limit” should only
become detectable 3–4 h after the beginning of the
experiment. Alternatively, if internalization factors
are different, incubation with Alu-TAMRA DNA
should immediately result in a TAMRA+ cell
subpopulation, with the percentage matching that of
the control (Alu-TAMRA, 1 h).
What we observed when testing this combination
was that, following pre-incubation with pUC19, the
percentage of Alu-TAMRA cells equaled the control
level (as in Alu-TAMRA 1 h). After 4 h, the second
wave of internalization occurs. No decrease in the
percentage of Alu-TAMRA-internalizing cells was
observed, when they were saturated by the
pre-incubation with plasmid DNA (Fig. 6b 2,4,5).
These results indicate that Krebs-2 cells use at least
two distinct internalization pathways for the uptake of
supercoiled plasmid DNA and linear TAMRA-labeled
Alu DNA (500 bp) (Fig. 6b). The conclusions of these




Fig. 7 Competition between Alu-TAMRA DNA and high-molecular weight human DNA or sonicated pEGFP-N1 plasmid for internalization into
Krebs-2 cells. a Addition of Alu-TAMRA DNA to Krebs-2 cells pre-incubated with human dsDNA for 1 h; b addition of Alu-TAMRA DNA to Krebs-2
cells pre-incubated sonicated pEGFP-N1 plasmid DNA. FACS plots and schematics of the experimental points analyzed are shown; c bar plot
summarizing the percentages of TAMRA+ cells. Baseline equals background fluorescence of untreated cells; control represents cells incubated for
1 h with 1 μg of either human dsDNA (blue) or sonicated pEGFP-N1 plasmid (red); upper limit represents percentage of TAMRA+ cells after 1 h
incubation with 1 μg Alu-TAMRA DNA; d results of an agarose gel electrophoresis showing fragment size distributions of the three eDNAs tested.
Brackets on the sides of the gel indicate average sizes of sonicated pEGFP-N1 (left) and human dsDNA (right) fragments. dsDNA double-stranded DNA
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using plasmid DNA and human dsDNA (300–6000 bp)
showing lack of competition between the two species
for internalization factors (Fig. 4a).
The final experimental series was performed to
estimate the competition between various types of
linear DNA. Two combinations were selected:
human DNA +Alu-TAMRA (Fig. 7a), and sonicated
pEGFP-N1 +Alu-TAMRA (Fig. 7b), and analyzed as
above.
4. human DNA+ Alu-TAMRA
Testing this combination helped address possible
competition with human genomic DNA sonicated to
the size of 300–6000 bp (as this DNA species was
previously demonstrated to internalize into Krebs-2
TISCs [12]). The results obtained show that
internalization factors for 300–6000 bp human DNA
(hereafter referred to as high-molecular weight
DNA) and human Alu repeat provided as a PCR
fragment are distinct (Fig. 7a and c). We observed
that there was partial competition between Alu
DNA and sonicated human DNA for internalization
factor(s), as demonstrated by the slight decrease in
Alu-TAMRA-internalizing cells. This is likely
attributable to the presence of trace amounts of
DNA below 500 bp in the sonicated human DNA
preparation, which serves as a competitor.
5. Sonicated pEGFP-N1 + Alu-TAMRA
Use of this combination focused the analysis on the
competition between DNA species similar in
structure and size (Fig. 7d). Internalization of 500 bp
Alu-TAMRA PCR product by Krebs-2 cells
pre-incubated with sonicated pEGFP-N1 plasmid
(<700 bp) was significantly suppressed, which
suggests competition for the internalization factor
(Fig. 7b and c).
Taken together, our data suggest that supercoiled
plasmid DNA reaches internal compartments of
Krebs-2 TISCs essentially intact, given that
functional plasmids can be recovered upon
transformation into competent E. coli cells. Hence, it
was interesting to test whether GFP could be
expressed from the pEGFP-N1 plasmid internalized
by Krebs-2 TISCs. Cells and the plasmid DNA were
co-incubated for 1 h. Then incubation medium was
replaced with a 10 % FBS-supplied medium, and
cells were kept in the CO2 incubator for another
24 h. We ensured pEGFP-N1 plasmid was fully
functional by incubating it with mouse fibroblasts.
In the presence of lipofectamine, about 70 % of cells
were scored GFP-positive. Two incubation protocols
were tested for Krebs-2 TISCs, one including
protamine, and one with protamine omitted. When
plasmid DNA was pre-incubated with protamine,
this resulted in a 17-fold increase in internalization
efficiency. Notably, in neither protocol was any GFP
fluorescence observed in Krebs-2 TISCs (Fig. 8a and
b). Control experiments involving Alu-TAMRA
DNA or Alu-TAMRA “pre-complexed” with
protamine indicate that the percentage of
DNA-internalizing cells remains unchanged (Fig. 8c).
This argues for the existence of an additional
internalization factor for DNA-protamine
complexes.
Discussion
In the present study, we performed comprehensive ana-
lysis of plasmid DNA internalization by Krebs-2 cells, and
established several interesting aspects of competition
between distinct DNA species upon internalization. To do
so, we developed a special approach wherein Krebs-2 cells
were first incubated or co-incubated with plasmid DNA;
total DNA was isolated from such cells and used for trans-
formation of competent E. coli cells. The rationale behind
this approach is that it is important to analyze whether
plasmid DNA can be used as a versatile vector to deliver
cell-killing genes to TISCs. Efficiency of internalization
was also assayed independently using qPCR.
About 3 % of mouse ascites Krebs-2 cells were shown
to internalize eDNA, such as TAMRA-5’-dUTP human
Alu DNA fragment (Fig. 1). Saturation of the cells by
Alu DNA fragments was achieved during the first hour
of incubation, and the quantity of internalized DNA
material doubled every 10 min. The efficiency of
internalization remained unaffected across a wide range of
temperatures tested (4 °С, 25 °С, and 37 °С).
We demonstrate that internalization of dsDNA (500 bp)
and supercoiled pUC19 plasmid DNA occurs in exactly
the same tumor cells (Fig. 2). The cell saturation threshold
with plasmid DNA was defined. When 1 μg plasmid DNA
is co-incubated with 106 Krebs-2 cells, ascites cells cannot
internalize more eDNA. Such cells encompass 340–2600
copies of the plasmid, depending on the transformation
experiment, or up to 3.097 ± 0.044×106 molecules, as
assayed by qPCR (Fig. 3). The approximate 1000-fold dif-
ference between the results obtained using these two quan-
tification methods is explained by the distinct sensitivities
of these approaches. The number of colonies obtained after
transformation is affected by many parameters, such as the
competence level of bacterial cells, sterical interactions of
circular plasmid DNA with chromatin, association of cellu-
lar proteins with the internalized plasmids, and structural
integrity of the plasmid. In contrast, these factors are of lit-
tle importance when PCR quantification is used, as it only
measures the number of target molecules delimited by the
primer binding sites.
When eDNA is condensed by forming complexes with a
positively charged protamine [9], this results in a 17-fold
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increase in internalization, with the percentage of DNA-
internalizing cells remaining unchanged.
Experiments were performed to analyze possible com-
petition between plasmid pUC19 and various forms of
nucleic acids (human dsDNA (300–6000 bp), PCR frag-
ment (500 bp), yeast RNA), as well as other agents (BSA,
heparin) for internalization by Krebs-2 cells. Of these, only
heparin worked as a potent inhibitor of internalization
(Fig. 4). These observations are consistent with the idea
that heparin interacts with the same internalization
factor(s) as plasmid DNA. Heparin was reported to inter-
act with a number of cell surface molecules, such as hep-
arin binding protein and CAP37/azurocidin [16]. Bennett
and colleagues showed that heparin and DNA molecules
compete for binding to a 30-kDa protein in the context of
lymphocyte membranes, whereas RNA, poly-dA/dT, or
dNTP mix do not [3]. Also, heparin is known to interact
with a family of fibroblast growth factor receptors [13].
Exosomes have been reported to contain dsDNA, and so
their cargo can be easily internalized—in a process that is
Fig. 8 Internalization of protamine/extracellular DNA complexes by Krebs-2 cells. a Analysis of GFP fluorescence in Krebs-2 cells following incubation
with pEGFP-N1 plasmid. DAPI represents chromatin (blue channel); FITC represents GFP (green channel, no signal). b Transformation of E. coli competent
cells with DNA isolated from Krebs-2 cells incubated with pEGFP-N1 or pEGFP-N1/protamine complexes. c FACS analysis of Alu-TAMRA DNA/protamine
internalization by Krebs-2 cells: 1: Negative control, intact Krebs-2 cells; 2: Krebs-2 + protamine; 3: Krebs-2 + Alu-TAMRA DNA; 4: Krebs-2 + Alu-TAMRA
DNA/protamine complexes. Percentage values correspond to autofluorescence levels observed in the control and to the fraction of TAMRA+ cells at
experimental points
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inhibited by heparin [8]. This could have pointed to the
possible involvement of exosomes in eDNA internaliza-
tion. We checked whether the TAMRA+ probe could be
effluxed by Krebs-2 TISCs and observed that, upon
internalization, the DNA did not leave the cells in any
form, including exosomal (data not shown). This indicates
that internalized DNA does not become part of exosomes,
at least in the given context. The formal possibility that an
exosome would internalize extracellular dsDNA appears
rather unlikely, nor has such a property been reported in
the literature. Given the above-described range of cell
receptors bound by heparin and its property to inhibit
eDNA internalization, one can expect that in the case of
Krebs-2 cells these cell surface proteins are bona fide
eDNA internalization factors.
Depending on the experiment, we observed increased
internalization (13–50 %) of plasmid DNA 3 h after the
beginning of incubation (Fig. 5). Formally, this observation
is compatible with two scenarios. The first implies that
internalization is mediated by specific cell receptors that
shuttle back and forth between the cell surface and the
cell interior [40]. The other relies on the greater availabil-
ity of internalization-competent cells. We showed that
TAMRA+ cells are the same cells as those internalizing
plasmid DNA, and that their percentage ranges 1–3 % in
our experiments. Under the first scenario, the percentage
of Alu-TAMRA internalizing cells should remain
unchanged at the 3- to 4-h timepoint; however, this was
not the case, and more TAMRA+ cells were observed 3 h
following the beginning of incubation (Fig. 5c). Thus, the
second scenario appears the likeliest. Internalization of
pUC19 translates into more colonies because more
internalization-competent Krebs-2 cells become available,
rather than because more plasmid copies are internalized.
Krebs-2 TISCs are not expected to internalize eDNA dur-
ing mitosis, yet they become internalization-competent
soon thereafter. Importantly, all other cells of this particular
cell subpopulation already contain eDNA molecules. Thus,
there should be a gain in DNA-internalizing cells that
should be equal to the proportion of cells found in the G2-
M phases in the beginning of the experiment, which in turn
should translate into more E. coli colonies formed upon
transformation. The cells that internalized DNA in G1 per-
sist until mitosis, which explains why cell cycle profiling
experiments failed to uncover significant accumulation of
TAMRA+ cells in any of the cell cycle phases (Fig. 5a, c
and e; [12]).
Finally, we tested competition between supercoiled plas-
mid DNA (pUC19), short PCR product (human Alu PCR
fragment, 500 bp), sonicated pEGFP-N1 plasmid
(100–700 bp), and larger-sized sonicated human
dsDNA (300–6000 bp). If internalization factors for
distinct types of DNA are the same, then saturating
pre-treatment with one DNA species should block
internalization of the other. Alternatively, should internal-
ization factors be distinct, the second DNA type should be
internalized regardless of the pre-treatment type of DNA.
It turned out that pre-treatment with Alu PCR fragment
abolishes subsequent internalization of Alu DNA and son-
icated pEGFP-N1 by Krebs-2 cells (Figs. 6a and 7b). We
attribute this to the fact that sonicated plasmid DNA is
similar in size (100–700 bp) to Alu fragment (500 bp),
thereby efficiently competing for binding to the receptor
that mediates internalization of small (up to 500 bp) DNA
fragments. The same was observed for plasmid DNA that
blocked its own internalization. Efficiency of protamine-
assisted eDNA internalization was also analyzed.
Pre-treatment of Krebs-2 cells with supercoiled plas-
mid DNA does not affect subsequent internalization of
Alu PCR fragment (Fig. 6b). This is unlike pre-treatment
with sonicated human dsDNA, which shows partial
inhibition of Alu-TAMRA DNA internalization by
Krebs-2 cells (Fig. 7a). We believe this partial inhibition
is due to the presence of small amounts of low-
molecular weight DNA fragments (<500 bp) in the prep-
aration of sonicated human DNA (300–6000 bp). Most
of the fragments in this preparation, however, are longer
than 1 kb, and so they do not compete for binding to
the internalization factor that mediates the uptake of
fragments below 500 bp.
Biological meaning and clinical significance of the
phenomenon observed
The phenomenon of internalization of extracellular
dsDNA by stem cells (SCs) and TISCs is broadly related
to the functioning of an organism as a single entity. We
speculate that continuous flow of a highly dynamic set
of extracellular DNA fragments through various SCs
may function as a mechanism that helps such cells sense
the genetic “image” of the body. Quantitative as well as
qualitative changes among these eDNA molecules are
interpreted by the multipotent cells as the clues setting
the direction of differentiation.
Upon internalization and reaching the internal
compartments of SCs and TISCs, eDNA may partici-
pate in many molecular processes. For instance, it is
known that: 1) Any free dsDNA ends, including the
ends of eDNA molecules, potently induce repair
cascades [23, 29, 41–43]. Our studies as well as other
reports indicate that, upon internalization, linear
plasmid DNA is partially digested at its termini and
is ligated to form a circle [11, 25, 32, 34]. 2) When
the cell is undergoing the repair of interstrand DNA
crosslinks induced by an earlier treatment with a cy-
tostatic drug, eDNA fragments delivered at this point
into the cell interfere with nucleotide excision repair
and homologous recombination repair phases. In the
context of murine CD34+ hematopoietic stem cells
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(HSCs), this results in the failure to give rise to
lymphoid cell lineage [10], whereas Krebs-2 TISCs
either die or become non-tumorigenic [33]. 3) When
the cells repairing radiation-induced dsDNA breaks
receive eDNA fragments, the latter interfere with the
non-homologous end-joining step, yet HSCs are res-
cued from the aberrant recovery of chromosomal
integrity and apoptosis. These surviving HSCs help
repopulate the murine hematopoietic system, thereby
protecting the animals from developing radiation
sickness and death, and increasing the survival of
lethally irradiated mice to 60–90 % [26]. Thus,
“planting” eDNA to TISCs in a timely manner, when
these cells are trying to repair the DNA, may
potently interfere with the repair process, and so
poorly differentiated cell types including TISCs either die
or profoundly alter their properties. Clearly, this approach
relies on fundamentally different principles of targeting
SCs and TISCs. One of the most intriguing questions then
is whether extracellular fragmented dsDNA may also
target solitary cancer cells that give rise to metastases and
which are known to be largely quiescent (and represent a
form of TISCs). The very existence of these cells prompts
for the careful analysis of many interesting questions
related to cancer biology and therapy [31, 38]. In the ab-
sence of experimental data, we propose several ideas on
the possible interplay between solitary cancer cells and
fragmented dsDNA. First, these cells may be imagined not
to internalize eDNA, and it is important to understand
why poorly differentiated cells otherwise classifiable as
TISCs fail to do so [12]. Alternatively, dormant cancer
cells do internalize dsDNA, but whether their quiescence
may prevent the fragmented DNA from efficiently inter-
fering with the aforementioned molecular processes re-
mains unclear. A number of so-called stress signals have
been reported to induce proliferation of dormant cancer
cells, which leads to the development of a metastasis [38].
dsDNA fragments internalized by solitary cancer cells
may be viewed as a classical stress signal. Our work, as
well as the data from other research groups, is consistent
with the following scenario. Free ends of internalized
dsDNA molecules launch a kinase cascade thereby leading
to the cell cycle arrest and block of cell division [23, 25,
29, 32, 41–43]. Our unpublished ex vivo studies indicate
that dsDNA fragments are delivered into CD34+ HSCs,
most of which are non-dividing, and paradoxically induce
their proliferation. We speculate that stalling of the cell
cycle prevents the HSC from reverting to the quiescent
state, thereby forcing the dsDNA-activated cell to prolifer-
ate [27]. This scenario may point to the possibility that
solitary cancer cells may be induced to proliferate by
extracellular DNA fragments, which should translate into
a clinically negative effect. Nevertheless, if dormant cancer
cells do internalize eDNA this may well be used as a tool
to selectively kill such cells, essentially in the same way as
recently proposed [33]. Thus, our approach primarily tar-
gets poorly differentiated cell types including TISCs. Ex-
pression of a toxic protein or other protein of interest
delivered to such cells in the form of DNA may be used
to selectively alter their phenotype or eliminate them
altogether.
Conclusion
Upon reaching the cell interior, eDNA molecules do not
behave as an inert cargo. They are actively integrated in
multiple on-going cellular processes and frequently com-
promise their correct progression. Additionally, extracellu-
lar DNA may also induce a number of cellular processes.
Finally, the very property of dsDNA internalization may
serve to develop a versatile approach to detect and target
any type of poorly differentiated cells, such as TISCs.
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